New to Medtech Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
Tandem Diabetes Care, Inc.
https://www.tandemdiabetes.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Tandem Diabetes Care, Inc.
Medtronic Claims Share Gains In Cardiovascular And Neurostim
The company’s revenue was down just 1% year-over-year in the third quarter of fiscal 2021, despite the ongoing impact of the pandemic.
Market Intel: Rivalry Among Insulin Pump Makers Heats Up With Expected Launches In 2021
The global insulin pump market is expected to see double-digit growth, reaching $5.1bn in 2024, with product launches expected by Medtronic, Insulet, Tandem and smaller players in 2021.
FDA Approves Medtronic’s Bluetooth-Enabled Insulin Pump For Children Ages 2 To 6
The US FDA approval of Medtronic’s Bluetooth-enabled MiniMed 770G in children as young as 2 paves the way for a PMA supplement of the next-gen MiniMed 780G.
Insulin Pump Market Heats Up Among Rivals Medtronic, Insulet and Tandem
Three major insulin pump developers are gearing up to introduce next-generation devices over the coming year, but COVID-19 continues to create uncertainties.
Company Information
- Industry
-
Pharmaceuticals
- Drug Delivery
-
Medical Devices
- Monitoring Equipment & Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
In Vitro Diagnostics
- Glucose Testing